Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

NovaBay Pharmaceuticals, Inc.

NBY•AMEX
Healthcare
Biotechnology
$2.10
$1.59(311.76%)
U.S. Market is Open • 12:24

NovaBay Pharmaceuticals, Inc. (NBY) Stock Overview

Explore NovaBay Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap79.7M
P/E Ratio1.14
EPS (TTM)$5.16
ROE1.09%
Fundamental Analysis

AI Price Forecasts

1 Month$-0.35
3 Months$5.45
1 Year Target$0.00

NBY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of NovaBay Pharmaceuticals, Inc. (NBY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 35.96, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 1.14 and a market capitalization of 79.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
20.63%
5-Day Change
0.87%
1-Month Change
-90.54%
3-Month Change
-37.86%
6-Month Change
-40.27%
Year-to-Date (YTD) Change
-89.52%
1-Year Change
-3.88%
3-Year Change
-99.22%
5-Year Change
-99.96%
All-Time (Max) Change
-100.00%

Contact Information

https://novabay.com
510 899 8800
2000 Powell Street, EmeryVille, CA, 94608

Company Facts

130 Employees
IPO DateOct 26, 2007
CountryUS
Actively Trading

Frequently Asked Questions